BIOMAT Database Logo BIOMAT Database Logo

The effect of celiprolol on peripheral circulation in healthy volunteers. 1985

H Ehringer, and U Konecny, and W Rasser

UI MeSH Term Description Entries
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008297 Male Males
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D017272 Celiprolol A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION. Celiprolol Hydrochloride,Celiprolol Monohydrochloride,Celiprolol, (+,-)-Isomer,Celiprolol, (R)-Isomer,Celiprolol, (S)-Isomer,Celiprolol, Monohydrochloride, (R)-Isomer,Celiprolol, Monohydrochloride, (S)-Isomer,N'-(3-Acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethylurea,REV-5320A,ST-1396,Selectol,Hydrochloride, Celiprolol,Monohydrochloride, Celiprolol,REV 5320A,REV5320A,ST 1396,ST1396

Related Publications

H Ehringer, and U Konecny, and W Rasser
Bioequivalence studies of celiprolol in healthy human volunteers.
July 1996, Indian journal of medical sciences,
H Ehringer, and U Konecny, and W Rasser
A pharmacokinetic evaluation of celiprolol in healthy elderly volunteers.
January 1986, Journal of cardiovascular pharmacology,
H Ehringer, and U Konecny, and W Rasser
Exercise metabolism in healthy volunteers taking celiprolol, atenolol, and placebo.
June 1997, British journal of sports medicine,
H Ehringer, and U Konecny, and W Rasser
Effect of alpha2B-adrenoceptor polymorphism on peripheral vasoconstriction in healthy volunteers.
March 2005, Anesthesiology,
H Ehringer, and U Konecny, and W Rasser
The cardiovascular effects of celiprolol in healthy volunteers and patients with coronary heart disease.
June 1985, British journal of clinical practice. Supplement,
H Ehringer, and U Konecny, and W Rasser
The effect of celiprolol on glomerular filtration rate and renal blood flow in patients with chronic renal impairment and healthy volunteers.
April 1992, British journal of clinical pharmacology,
H Ehringer, and U Konecny, and W Rasser
Exercise increases endostatin in circulation of healthy volunteers.
January 2004, BMC physiology,
H Ehringer, and U Konecny, and W Rasser
Effect of celiprolol on large and small arteries of the forearm circulation in hypertensive patients.
June 1990, Cardiovascular drugs and therapy,
H Ehringer, and U Konecny, and W Rasser
Effect of folic acid on nitrate tolerance in healthy volunteers: differences between arterial and venous circulation.
February 2003, Journal of cardiovascular pharmacology,
H Ehringer, and U Konecny, and W Rasser
Comparative enantioselective pharmacokinetic studies of celiprolol in healthy volunteers and patients with impaired renal function.
January 1990, European journal of clinical pharmacology,
Copied contents to your clipboard!